126 filings
Page 5 of 7
424B4
dfaz74w
1 Oct 20
Prospectus supplement with pricing info
4:21pm
EFFECT
z5lnml5wkuk9oekxid
1 Oct 20
Notice of effectiveness
12:15am
CORRESP
o6chu0q9v9a14gszp
28 Sep 20
Correspondence with SEC
12:00am
CORRESP
5dpat
28 Sep 20
Correspondence with SEC
12:00am
UPLOAD
a54vnag
23 Sep 20
Letter from SEC
12:00am
DRS
5eejhchka2nlh
18 Sep 20
Draft registration statement
12:00am
DRSLTR
sg6 er1t08wai22h
18 Sep 20
Correspondence regarding draft registration statement
12:00am
8-K
kkddfg75fo
12 Aug 20
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second Quarter 2020 Results
7:30am
8-K
3mcmbggt2k0aooriwx
29 Jun 20
Regulation FD Disclosure
9:28am
10-Q
44c83kjld4v1q0r
12 May 20
Quarterly report
4:14pm
8-K
n2gphp ofr
12 May 20
Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results
10:52am
10-K
3gk8u2cqrkj7 foi9i
30 Mar 20
Annual report
5:26pm
8-K
g0ljcv1gso7m4t
30 Mar 20
Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results
6:45am
S-8
wmdibhc 671
24 Feb 20
Registration of securities for employees
12:00am
8-K
gt2xg15 pss
11 Feb 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
6h3 a34bieowqg
7 Feb 20
Prospectus supplement with pricing info
12:00am
EFFECT
m5jy 9uqmcyw3
6 Feb 20
Notice of effectiveness
12:15am
S-1MEF
wlbtq1rv6wx
5 Feb 20
Registration of additional securities for an S-1
9:17pm